C12N 2501/36
Somatostatin
C12N2501/36 (Somatostatin) appears on 7 US grants and 13 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 13
- Assignees
- 12
- Inventors
- 31
- Latest grant
- 7 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 3 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 2 | 0 |
| 2022 | 0 | 2 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Use of ENTPD3 for identification, isolation, and enhancing mature stem cell derived insulin-producing cells7 Apr 2026US 12,594,306 B2The Regents of the University of Colorado, a body corporate
- Method for preparing osteoblasts and osteoblast inducer16 Nov 2021US 11,174,464 B2Kyoto Prefectural Public University Corporation
- In vitro production of cholangiocytes1 Jun 2021US 11,021,686 B2Cambridge Enterprise Limited
- Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification4 Feb 2020US 10,548,908 B2Nostopharma, LLC
- Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification29 Oct 2019US 10,456,409 B2Nostopharma, LLC
- Thyrocytes and uses thereof17 Sep 2026US 2026/0275279 A1LifeNet Health
- Use of entpd3 for identification, isolation, and enhancing mature stem cell derived insulin-producing cells22 Sep 2022US 2022/0296652 A1The Regents of the University of Colorado, a body corporate
- Methods for generating induced pluripotent stem cells via cell cycle synchronization28 Jul 2022US 2022/0235329 A1Orig3n, Inc.
- Compositions and Methods for Preventing and Treating Heterotopic Ossification and Pathologic Calcification13 Jun 2019US 2019/0175621 A1Nostopharma, LLC
- Methods for generating induced pluripotent stem cells via cell cycle synchronization30 Aug 2018US 2018/0245051 A1Orig3n, Inc.
Most cited
By later US patents
- Embryonic stem cells capable of differentiating into desired cell lines42US 6,432,711 B1Diacrin, Inc. · 2002
- Clinical determination and/or quantification of thyrotropin and a variety of thyroid stimulatory or inhibitory factors performed in vitro with an improved thyroid cell line, FRTL-520US 4,609,622 AInterthyr Research Foundation, Inc. · 1986
- Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification1US 10,456,409 B2Nostopharma, LLC · 2019